Medtronic announces the departure of Karen Parkhill, Chief Financial Officer

DUBLIN, June 26, 2024 /CNW/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Karen Parkhill will resign as executive vice president and chief financial officer to accept the role of chief financial officer of HP Inc.

“On behalf of our employees, Executive Committee and Board of Directors, I would like to thank Karen for her leadership over the past eight years. I am personally grateful to Karen for her support throughout my transition to CEO, navigating the pandemic and delivering a new operating model for the company. We wish her all the best as she embarks on the next chapter of her career,” said Geoff Martha, President and CEO of Medtronic. “Across the company, we are building momentum through our innovation-led growth strategy, and we remain focused and committed to achieving our short- and long-term financial goals.

“It has been a pleasure to serve Medtronic and our mission over the past eight years,” Parkhill said. “I am grateful to have had the opportunity to lead Medtronic’s exceptional finance team, and I know they will continue to deliver on our commitments. I remain excited about Medtronic’s plans for the future and, above all, the enormous impact Medtronic technologies will have on the lives of patients around the world. »

The company evaluates internal and external succession candidates. Parkhill will continue in her role as CFO until her departure on August 2ndAnd Gary CoronaSenior Vice President, Global Financial Planning and Analysis, will serve as interim CFO following her departure.

Additionally, the company also reaffirmed its guidance for its first quarter and full year 2025, as previously stated in its report. May 23, 2024press release on results and webcast.

About Medtronic
A bold thought. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the global health technology leader that boldly tackles the most challenging health problems facing humanity by researching and finding solutions. Our mission – to relieve pain, restore health and extend life – brings together a global team of more than 95,000 passionate people in more than 150 countries. Our technologies and therapies address 70 health conditions and include cardiac devices, surgical robots, insulin pumps, surgical tools, patient monitoring systems, and more. With our diverse knowledge, insatiable curiosity and desire to help everyone in need, we deliver innovative technologies that transform the lives of two people every second, every hour and every day. Expect more from us as we drive knowledge-driven care, people-first experiences, and better outcomes for our world. In everything we do, we design the extraordinary. For more information about Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

The story continues

Forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks relating to competitive factors, difficulties and delays inherent in the development, the manufacture, marketing and sale of medical products, government regulation, geopolitical conflicts, general economic conditions and other risks and uncertainties described in the Company’s periodic reports filed with the United States Securities and Exchange Commission, including including the Company’s most recent Annual Report on Form 10-K. Medtronic undertakes no obligation to update its forward-looking statements, including to reflect future events or circumstances.

View original content to download multimedia: https://www.prnewswire.com/news-releases/medtronic-announces-departure-of-karen-parkhill-chief-financial-officer-302182527.html

SOURCE Medtronic plc

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2024/26/c1704.html